Literature DB >> 9222110

Detailed analysis of cell cycle kinetics upon proteasome inhibition.

B M Machiels1, M E Henfling, W L Gerards, J L Broers, H Bloemendal, F C Ramaekers, B Schutte.   

Abstract

We have studied specific effects of proteasome inhibition on cell cycle progression. To this end, the protease inhibitors MG115, calpain inhibitor I, and calpain inhibitor II, which display differential inhibitory effects on proteasomes, were used. Cell kinetic studies using bromodeoxyuridine pulse labeling revealed a complete block of G1/S and metaphase transitions and a delayed progression through S phase in cell cultures treated with 54 microM of MG115. Calpain inhibitor I in similar concentrations displayed a fivefold lower effect on cell cycle kinetics. Calpain inhibitor II and MG2M, which is a structural analogue of MG115, had no effect on the cell cycle. The inhibitory effect of MG115 treatment was reversible, because the cell cycle was immediately resumed when the MG115-containing culture medium was replaced by fresh culture medium. Because ubiquitinated proteins accumulated after MG115 treatment, it was confirmed that ubiquitin-dependent protein degradation, and thus proteasomal activity were blocked. By comparison of biochemical and in vitro proteasome inhibition experiments, it was hypothesized that chymotrypsin-like activity of proteasomes may play an important role in cell cycle kinetics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222110

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  12 in total

1.  Quantitative immunofluorescence assay to measure the variation in protein levels at centrosomes.

Authors:  Shubhra Majumder; Harold A Fisk
Journal:  J Vis Exp       Date:  2014-12-20       Impact factor: 1.355

Review 2.  Proteasome inhibition: a new strategy in cancer treatment.

Authors:  J Adams; V J Palombella; P J Elliott
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

3.  Evidence against a direct antiviral activity of the proteasome during the early steps of HIV-1 replication.

Authors:  Megan Dueck; John Guatelli
Journal:  Virology       Date:  2007-02-21       Impact factor: 3.616

4.  Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion.

Authors:  Ivana Zavrski; Cord Naujokat; Kathrin Niemöller; Christian Jakob; Ulrike Heider; Corinna Langelotz; Claudia Fleissner; Jan Eucker; Kurt Possinger; Orhan Sezer
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-08       Impact factor: 4.553

Review 5.  Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review.

Authors:  John Koreth; Edwin P Alyea; William J Murphy; Lisbeth A Welniak
Journal:  Biol Blood Marrow Transplant       Date:  2009-12       Impact factor: 5.742

6.  Caffeic Acid Phenylethyl Ester and MG-132 Have Apoptotic and Antiproliferative Effects on Leukemic Cells But Not on Normal Mononuclear Cells.

Authors:  Victoria Cavaliere; Daniela L Papademetrio; Mario Lorenzetti; Pamela Valva; María Victoria Preciado; Patricia Gargallo; Irene Larripa; Mariela B Monreal; María Laura Pardo; Silvia E Hajos; Guillermo Ac Blanco; Elida Mc Alvarez
Journal:  Transl Oncol       Date:  2009-03       Impact factor: 4.243

7.  Synthesis and evaluation of tiaprofenic acid-derived UCHL5 deubiquitinase inhibitors.

Authors:  Harshani S Gurusingha Arachchige; Poornima D H Herath Mudiyanselage; Garrett C VanHecke; Kush Patel; Hassan A Cheaito; Q Ping Dou; Young-Hoon Ahn
Journal:  Bioorg Med Chem       Date:  2020-12-09       Impact factor: 3.641

Review 8.  The emerging role of bortezomib in the treatment of indolent non-Hodgkin's and mantle cell lymphomas.

Authors:  Owen A O'Connor
Journal:  Curr Treat Options Oncol       Date:  2004-08

9.  The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism.

Authors:  Frank Pajonk; Arndt van Ophoven; Christian Weissenberger; William H McBride
Journal:  BMC Cancer       Date:  2005-07-07       Impact factor: 4.430

10.  Transcriptional Activation of Pericentromeric Satellite Repeats and Disruption of Centromeric Clustering upon Proteasome Inhibition.

Authors:  Theona Natisvili; Cihangir Yandim; Raquel Silva; Giulia Emanuelli; Felix Krueger; Sathiji Nageshwaran; Richard Festenstein
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.